This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ACP-006

Ascendis Pharma A/S

Drug Names(s): TransCon Hydrogel Pramipexole

Description: TransCon Hydrogel Pramipexole is a subcutaneous reformulation of Mirapex, a dopamine agonist. It aims to improve efficacy and compliance by replacing multiple oral dosages with a once-weekly subcutaneous injection using a small 30G needle.


ACP-006 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug